U Heilmeier1, K Cheng2, C Pasco2, R Parrish2, J Nirody3, J M Patsch4,5, C A Zhang6, G B Joseph4, A J Burghardt4, A V Schwartz6, T M Link4, G Kazakia4. 1. Musculoskeletal Quantitative Imaging Research Group, Department of Radiology & Biomedical Imaging, University of California San Francisco, 185 Berry Street, San Francisco, CA, 94158, USA. Ursula.Heilmeier@ucsf.edu. 2. Department of Bioengineering, University of California Berkeley, 306 Stanley Hall, Berkeley, CA, 94720, USA. 3. Biophysics Graduate Group, University of California Berkeley, 574 Stanley Hall, MC 3220, Berkeley, CA, 94720, USA. 4. Musculoskeletal Quantitative Imaging Research Group, Department of Radiology & Biomedical Imaging, University of California San Francisco, 185 Berry Street, San Francisco, CA, 94158, USA. 5. Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. 6. Department of Epidemiology and Biostatistics, University of California San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.
Abstract
UNLABELLED: We investigated the characteristics and spatial distribution of cortical bone pores in postmenopausal women with type 2 diabetes (T2D). High porosity in the midcortical and periosteal layers in T2D subjects with fragility fractures suggests that these cortical zones might be particularly susceptible to T2D-induced toxicity and may reflect cortical microangiopathy. INTRODUCTION: Elevated cortical porosity is regarded as one of the main contributors to the high skeletal fragility in T2D. However, to date, it remains unclear if diabetic cortical porosity results from vascular cortical changes or from an expansion in bone marrow space. Here, we used a novel cortical laminar analysis technique to investigate the characteristics and spatial radial distribution of cortical pores in a T2D group with prior history of fragility fractures (DMFx, assigned high-risk group) and a fracture-free T2D group (DM, assigned low-risk group) and to compare their results to non-diabetic controls with (Fx) and without fragility fractures (Co). METHODS: Eighty postmenopausal women (n = 20/group) underwent high-resolution peripheral quantitative computed tomography (HR-pQCT) of the distal tibia and radius. Cortical bone was divided into three layers of equal width including an endosteal, midcortical, and periosteal layer. Within each layer, total pore area (TPA), total pore number (TPN), and average pore area (APA) were calculated. Statistical analysis employed Mann-Whitney tests and ANOVA with post hoc tests. RESULTS: Compared to the DM group, DMFx subjects exhibited +90 to +365 % elevated global porosity (p = 0.001). Cortical laminar analysis revealed that this increased porosity was for both skeletal sites confined to the midcortical layer, followed by the periosteal layer (midcortical +1327 % TPA, p ≤ 0.001, periosteal +634 % TPA, p = 0.002), and was associated in both layers and skeletal sites with high TPN (+430 % TPN, p < 0.001) and high APA (+71.5 % APA, p < 0.001). CONCLUSION: High porosity in the midcortical and periosteal layers in the high-risk T2D group suggests that these cortical zones might be particularly susceptible to T2D-induced toxicity and may reflect cortical microangiopathy.
UNLABELLED: We investigated the characteristics and spatial distribution of cortical bone pores in postmenopausal women with type 2 diabetes (T2D). High porosity in the midcortical and periosteal layers in T2D subjects with fragility fractures suggests that these cortical zones might be particularly susceptible to T2D-induced toxicity and may reflect cortical microangiopathy. INTRODUCTION: Elevated cortical porosity is regarded as one of the main contributors to the high skeletal fragility in T2D. However, to date, it remains unclear if diabetic cortical porosity results from vascular cortical changes or from an expansion in bone marrow space. Here, we used a novel cortical laminar analysis technique to investigate the characteristics and spatial radial distribution of cortical pores in a T2D group with prior history of fragility fractures (DMFx, assigned high-risk group) and a fracture-free T2D group (DM, assigned low-risk group) and to compare their results to non-diabetic controls with (Fx) and without fragility fractures (Co). METHODS: Eighty postmenopausal women (n = 20/group) underwent high-resolution peripheral quantitative computed tomography (HR-pQCT) of the distal tibia and radius. Cortical bone was divided into three layers of equal width including an endosteal, midcortical, and periosteal layer. Within each layer, total pore area (TPA), total pore number (TPN), and average pore area (APA) were calculated. Statistical analysis employed Mann-Whitney tests and ANOVA with post hoc tests. RESULTS: Compared to the DM group, DMFx subjects exhibited +90 to +365 % elevated global porosity (p = 0.001). Cortical laminar analysis revealed that this increased porosity was for both skeletal sites confined to the midcortical layer, followed by the periosteal layer (midcortical +1327 % TPA, p ≤ 0.001, periosteal +634 % TPA, p = 0.002), and was associated in both layers and skeletal sites with high TPN (+430 % TPN, p < 0.001) and high APA (+71.5 % APA, p < 0.001). CONCLUSION: High porosity in the midcortical and periosteal layers in the high-risk T2D group suggests that these cortical zones might be particularly susceptible to T2D-induced toxicity and may reflect cortical microangiopathy.
Entities:
Keywords:
Cortical bone laminar analysis; Cortical pore distribution; Cortical pore number; Cortical porosity; Diabetic bone disease; Type 2 diabetes
Authors: Yohann Bala; Roland Chapurlat; Angela M Cheung; Dieter Felsenberg; Michel LaRoche; Edward Morris; Jonathan Reeve; Thierry Thomas; Jose Zanchetta; Oliver Bock; Ali Ghasem-Zadeh; Roger Martin Zebaze Djoumessi; Ego Seeman; René Rizzoli Journal: J Bone Miner Res Date: 2014-02 Impact factor: 6.741
Authors: U Heilmeier; D R Carpenter; J M Patsch; R Harnish; G B Joseph; A J Burghardt; T Baum; A V Schwartz; T F Lang; T M Link Journal: Osteoporos Int Date: 2015-01-13 Impact factor: 4.507
Authors: Yohann Bala; Roger Zebaze; Ali Ghasem-Zadeh; Elizabeth J Atkinson; Sandra Iuliano; James M Peterson; Shreyasee Amin; Åshild Bjørnerem; L Joseph Melton; Helena Johansson; John A Kanis; Sundeep Khosla; Ego Seeman Journal: J Bone Miner Res Date: 2014-06 Impact factor: 6.741
Authors: Janina M Patsch; Xiaojuan Li; Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Ann V Schwartz; Thomas M Link Journal: J Bone Miner Res Date: 2013-08 Impact factor: 6.741
Authors: João Paulo B Ximenez; Ariane Zamarioli; Melissa A Kacena; Rommel Melgaço Barbosa; Fernando Barbosa Journal: Biol Trace Elem Res Date: 2020-04-30 Impact factor: 3.738
Authors: Kathryn M Thrailkill; R Clay Bunn; Sasidhar Uppuganti; Philip Ray; Iuliana Popescu; Evangelia Kalaitzoglou; John L Fowlkes; Jeffry S Nyman Journal: Bone Date: 2020-09-02 Impact factor: 4.398
Authors: Po-Hung Wu; Matthew Gibbons; Sarah C Foreman; Julio Carballido-Gamio; Misung Han; Roland Krug; Jing Liu; Thomas M Link; Galateia J Kazakia Journal: Quant Imaging Med Surg Date: 2019-06
Authors: Parinya Samakkarnthai; Jad G Sfeir; Elizabeth J Atkinson; Sara J Achenbach; Paul W Wennberg; Peter J Dyck; Amanda J Tweed; Tammie L Volkman; Shreyasee Amin; Joshua N Farr; Adrian Vella; Matthew T Drake; Sundeep Khosla Journal: J Clin Endocrinol Metab Date: 2020-10-01 Impact factor: 5.958
Authors: Saghi Sadoughi; Courtney Pasco; Gabby B Joseph; Po-Hung Wu; Anne L Schafer; Galateia J Kazakia Journal: J Bone Miner Res Date: 2022-02-08 Impact factor: 6.390